The Valley Desk

NCT06388083 · Interventional trial

A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease

Overall registry status Active not recruiting

Phase 2 · Phase 3

Conditions STGD1, Stargardt Disease 1

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov